Compare ArcelorMittal SA (MT) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ArcelorMittal SA vs Novavax Inc — how do they compare? ArcelorMittal SA trades at $66.25 (market cap $50.01B), while Novavax Inc trades at $8.08 (market cap $1.30B). The key difference: ArcelorMittal SA is far larger — about 38.5× Novavax Inc's market cap, and ArcelorMittal SA pays a 0.91% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| MT | NVAX | |
|---|---|---|
Market Cap | $50.01B | $1.30B |
Sector | Basic Materials | Health |
52-Week High | $71.65 | $11.19 |
52-Week Low | $30.39 | $6.22 |
Enterprise Value | $59.33B | $800.50M |
Dividend Yield | 0.91% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
